ES358505A1 - Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas. - Google Patents

Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.

Info

Publication number: ES358505A1
Authority: ES; Spain
Prior art keywords: nylon; mixtures; sustained release; release tablet; tablet coating
Prior art date: 1967-09-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

ES358505A

Other languages

English (en)

Spanish (es)

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SIXTEN ENGLESSON TEKNISK KONSULT

Original Assignee

SIXTEN ENGLESSON TEKNISK KONSULT

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1967-09-04

Filing date

1968-09-25

Publication date

1970-04-16

1968-09-25 Application filed by SIXTEN ENGLESSON TEKNISK KONSULT filed Critical SIXTEN ENGLESSON TEKNISK KONSULT

1970-04-16 Publication of ES358505A1 publication Critical patent/ES358505A1/es

Status Expired legal-status Critical Current

Links

239000007939 sustained release tablet Substances 0.000 title 1
238000009492 tablet coating Methods 0.000 title 1
239000000203 mixture Substances 0.000 abstract 4
KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 abstract 2
239000004677 Nylon Substances 0.000 abstract 2
239000004952 Polyamide Substances 0.000 abstract 2
WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 abstract 2
239000011248 coating agent Substances 0.000 abstract 2
238000000576 coating method Methods 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
229920001778 nylon Polymers 0.000 abstract 2
XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 abstract 2
229920002647 polyamide Polymers 0.000 abstract 2
LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 abstract 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
229930008281 A03AD01 - Papaverine Natural products 0.000 abstract 1
JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 abstract 1
229920000571 Nylon 11 Polymers 0.000 abstract 1
229920000299 Nylon 12 Polymers 0.000 abstract 1
229920002292 Nylon 6 Polymers 0.000 abstract 1
235000011037 adipic acid Nutrition 0.000 abstract 1
239000001361 adipic acid Substances 0.000 abstract 1
230000001476 alcoholic effect Effects 0.000 abstract 1
VEQOALNAAJBPNY-UHFFFAOYSA-N antipyrine Chemical compound CN1C(C)=CC(=O)N1C1=CC=CC=C1 VEQOALNAAJBPNY-UHFFFAOYSA-N 0.000 abstract 1
LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 abstract 1
239000007859 condensation product Substances 0.000 abstract 1
KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 1
239000000839 emulsion Substances 0.000 abstract 1
229960002179 ephedrine Drugs 0.000 abstract 1
210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000000463 material Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
229960003512 nicotinic acid Drugs 0.000 abstract 1
235000001968 nicotinic acid Nutrition 0.000 abstract 1
239000011664 nicotinic acid Substances 0.000 abstract 1
229960001789 papaverine Drugs 0.000 abstract 1
229960005222 phenazone Drugs 0.000 abstract 1
229960001404 quinidine Drugs 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1
229960000278 theophylline Drugs 0.000 abstract 1
JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)

ES358505A 1967-09-04 1968-09-25 Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas. Expired ES358505A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE1219667A SE324859B (fr)	1967-09-04	1967-09-04

Publications (1)

Publication Number	Publication Date
ES358505A1 true ES358505A1 (es)	1970-04-16

Family

ID=20295314

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES358505A Expired ES358505A1 (es)	1967-09-04	1968-09-25	Un dispositivo combinado de sustentacion y propulsion para embarcaciones maritimas.

Country Status (7)

Country	Link
AT (1)	AT280478B (fr)
BE (1)	BE720383A (fr)
ES (1)	ES358505A1 (fr)
FR (1)	FR8105M (fr)
GB (1)	GB1186990A (fr)
NL (1)	NL6812365A (fr)
SE (1)	SE324859B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU174057B (hu) *	1976-09-17	1979-10-28	Richter Gedeon Vegyeszet	Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva
DE3573884D1 (en) *	1982-07-08	1989-11-30	Leo Ab	Substained release tablets and method for preparation thereof
USRE33994E (en) *	1983-08-16	1992-07-14	Burroughs Wellcome Co.	Pharmaceutical delivery system
EP0171457B1 (fr) *	1984-08-17	1992-03-25	The Wellcome Foundation Limited	Composition à libération contrôlée d'une substance active et sa fabrication
GB8322007D0 (en) *	1983-08-16	1983-09-21	Wellcome Found	Pharmaceutical delivery system
US5178868A (en) *	1988-10-26	1993-01-12	Kabi Pharmacia Aktiebolaq	Dosage form
CN100408560C (zh) *	1998-10-09	2008-08-06	味之素株式会社	半胱氨酸衍生物

1967
- 1967-09-04 SE SE1219667A patent/SE324859B/xx unknown
1968
- 1968-08-29 AT AT838268A patent/AT280478B/de not_active IP Right Cessation
- 1968-08-29 GB GB41287/68A patent/GB1186990A/en not_active Expired
- 1968-08-30 NL NL6812365A patent/NL6812365A/xx unknown
- 1968-09-04 BE BE720383D patent/BE720383A/xx unknown
- 1968-09-25 ES ES358505A patent/ES358505A1/es not_active Expired
- 1968-11-26 FR FR175388A patent/FR8105M/fr not_active Expired

Also Published As

Publication number	Publication date
NL6812365A (fr)	1969-03-06
GB1186990A (en)	1970-04-08
SE324859B (fr)	1970-06-15
AT280478B (de)	1970-04-10
FR8105M (fr)	1970-07-27
BE720383A (fr)	1969-02-17

Similar Documents

Publication	Publication Date	Title
ATE99927T1 (de)	1994-01-15	Pharmazeutische formulierungen.
DE3686936D1 (de)	1992-11-12	Am zielorgan wirkendes enterales abgabesystem.
FI86373B (fi)	1992-05-15	Belaeggning foer en farmaceutiskt tablett med foerdroejd effekt och foerfarande foer framstaellning av en tablett.
GB1186990A (en)	1970-04-08	Sustained Release Tablet Coating.
GB1210968A (en)	1970-11-04	Improvements in or relating to the treatment of gastric ailments
GB1391746A (en)	1975-04-23	Stimulative composition and process for its production
Elsmore	1972	Saccharine aversion induced by delta-9-tetrahydrocannabinol: Effects of repeated doses prior to pairing with saccharine.
ES361702A1 (es)	1970-11-16	Un procedimiento para la preparacion de sales de acido oro-tico yno acido dihidroorotico.
ES265597A1 (es)	1961-06-01	Un metodo para la preparaciën de un nuevo y util derivado del antibiëtico kanamicina
IE38235L (en)	1974-03-15	Combatting swine dysentery
GB1263839A (en)	1972-02-16	A novel aminoethanesulfonic acid
GB1019111A (en)	1966-02-02	Salts of 5-amino-isoindoline
Cooper et al.	1973	Plasma-level studies of chlorpromazine following the administration of chlorpromazine hydrochloride and chlorpromazine embonate in chronic schizophrenics.
ISHIHARA et al.	1979	Experimental investigation on the pathogenesis of tartrazine-induced asthma
GB908634A (en)	1962-10-24	Pharmaceutical compositions containing pararosaniline or derivatives thereof
Davidson et al.	1970	The Effect of Chronic Reserpine Administration on Vanilmandelic Acid Excretion, Blood Pressure and Pulse Rate in Normal Men
RU14513U1 (ru)	2000-08-10	Интерферонсодержащий препарат
GB1110397A (en)	1968-04-18	Ephedrine composition
Pojda et al.	1975	The activation of the renin--angiotensin system in the dog after injection of noradrenaline into the lateral brain ventricle
Nottage et al.	1978	Effect of lithium on voluntary alcohol consumption by low and high preference mouse strains
JPS51123834A (en)	1976-10-28	A medicine against the headache
GB1284884A (en)	1972-08-09	A new insoluble salt of kanamycin
GB1350309A (en)	1974-04-18	Acetylsalicylic acid derivative method for its preparation and therapeutic composition containing same
Nagai et al.	1988	Clinical studies on enoxacin in urinary tract infection
Aleutskiĭ et al.	1975	Study of the effect of tetracycline carboxamide derivatives on the cardiovascular and urinary systems